Host genetic factors and vaccine-induced immunity to HBV infection: Haplotype analysis

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Ryckman, Kelli K ^a,b   Fielding, Katherine ^c   Hill, Adrian V ^d   Mendy, Maimuna ^e   Rayco Solon, Pura ^e   Sirugo, Giorgio ^f   van der Sande, Marianne A ^e,g   Waight, Pauline ^e   Whittle, Hilton C ^e   Hall, Andrew J ^c   Williams, Scott M ^a   Hennig, Branwen J ^e  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^f FATEBENEFRATELLI HOSPITAL   (Italy)

^g NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; HERMES ANTIGEN; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 19; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; PROTEIN CDC42; IL19 PROTEIN, HUMAN; IL1R1 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; LEUKOCYTE ANTIGEN; VIRUS VACCINE;

ARTICLE; CHILD; COHORT ANALYSIS; FEMALE; GAMBIA; GENETIC ANALYSIS; GENETIC ASSOCIATION; HAPLOTYPE; HEPATITIS B; HEREDITY; HUMAN; IMMUNITY; MALE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; GENETICS; IMMUNOLOGY;

HEPATITIS B VIRUS;

ADOLESCENT; ANTIGENS, CD; FEMALE; HAPLOTYPES; HEPATITIS B; HUMANS; IMMUNITY; INTERLEUKINS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-1 TYPE I; VIRAL VACCINES;

EID: 77957902780     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012273     Document Type: Article

References (29)

1. [Anonymous] (2009) Hepatitis B fact sheet.
2. van der Sande MA, Waight P, Mendy M, Rayco-Solon P, Hutt P, et al. (2006) Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis 193: 1528-1535. JID34354 [pii];10.1086/503433 [doi].
3. Zuckerman JN (2006) Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol 78: 169-177. 10.1002/jmv.20524 [doi].
4. Van LH, Van Amsterdam JG, Vandebriel RJ, Kimman TG, Rumke HC, et al. (2001) Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Environ Health Perspect 109: 757-764. sc271_5_1835 [pii].
5. Alper CA (1995) The human immune response to hepatitis B surface antigen. Exp Clin Immunogenet 12: 171-181.
6. Hohler T, Stradmann-Bellinghausen B, Starke R, Sanger R, Victor A, et al. (2002) C4A deficiency and nonresponse to hepatitis B vaccination. J Hepatol 37: 387-392. S0168827802002052 [pii].
7. Kimman TG, Vandebriel RJ, Hoebee B (2007) Genetic variation in the response to vaccination. Community Genet 10: 201-217. 000106559 [pii];10.1159/000106559 [doi].
8. Kruger A, Adams P, Hammer J, Bocher WO, Schneider PM, et al. (2005) Hepatitis B surface antigen presentation and HLA-DRB1*- lessons from twins and peptide binding studies. Clin Exp Immunol 140: 325-332. CEI2765 [pii];10.1111/j.1365-2249.2005.02765.x [doi].
9. Lin TM, Chen CJ, Wu MM, Yang CS, Chen JS, et al. (1989) Hepatitis B virus markers in Chinese twins. Anticancer Res 9: 737-741.
10. Newport MJ, Goetghebuer T, Weiss HA, Whittle H, Siegrist CA, et al. (2004) Genetic regulation of immune responses to vaccines in early life. Genes Immun 5: 122-129. 10.1038/sj.gene.6364051 [doi];6364051 [pii].
11. Sirugo G, Hennig BJ, Adeyemo AA, Matimba A, Newport MJ, et al. (2008) Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics. Hum Genet 123: 557-598. 10.1007/s00439-008-0511-y [doi].
12. Kimura K, Nagaki M, Saio M, Moriwaki H, Kakimi K (2009) Role of CD44 in CTL-induced acute liver injury in hepatitis B virus transgenic mice. J Gastroenterol 44: 218-227. 10.1007/s00535-008-2300-8 [doi].
13. Milich DR, Leroux-Roels GG (2003) Immunogenetics of the response to HbsAg vaccination. Autoimmun Rev 2: 248-257. S1568997203000314 [pii].
14. Thursz M (2001) MHC and the viral hepatitides. QJM 94: 287-291.
15. Wang C, Tang J, Song W, Lobashevsky E, Wilson CM, et al. (2004) HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 39: 978-988. 10.1002/hep.20142 [doi].
16. Davila S, Froeling FE, Tan A, Bonnard C, Boland GJ, et al. (2010) New genetic associations detected in a host response study to hepatitis B vaccine. Genes Immun 11: 232-238. gene20101 [pii];10.1038/gene.2010.1 [doi].
17. Hennig BJ, Fielding K, Broxholme J, Diatta M, Mendy M, et al. (2008) Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS One 3: e1898. 10.1371/journal.pone.0001898 [doi].
18. Clark AG (2004) The role of haplotypes in candidate gene studies. Genet Epidemiol 27: 321-333.
19. Morris RW, Kaplan NL (2002) On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 23: 221-233. 10.1002/gepi.10200 [doi].
20. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
21. Dudbridge F (2008) Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66: 87-98. 000119108 [pii];10.1159/000119108 [doi].
22. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate - A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological 57: 289-300.
23. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
24. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
25. Hodge JW, Chakraborty M, Kudo-Saito C, Garnett CT, Schlom J (2005) Multiple costimulatory modalities enhance CTL avidity. J Immunol 174: 5994-6004. 174/10/5994 [pii].
26. Tan TL, Fang N, Neo TL, Singh P, Zhang J, et al. (2008) Rac1 GTPase is activated by hepatitis B virus replication-involvement of HBX. Biochim Biophys Acta 1783: 360-374. S0167-4889(07)00270-4 [pii];10.1016/j.bbamcr.2007.10.024 [doi].
27. Brazzoli M, Bianchi A, Filippini S, Weiner A, Zhu Q, et al. (2008) CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes. J Virol 82: 8316-8329. JVI.00665-08 [pii];10.1128/JVI.00665-08 [doi].
28. Commins S, Steinke JW, Borish L (2008) The extended IL-10 superfamily: IL- 10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 121: 1108-1111. S0091-6749(08)00410-7 [pii];10.1016/j.jaci.2008.02.026 [doi].
29. Stanley SL, Jr., Frey SE, Taillon-Miller P, Guo J, Miller RD, et al. (2007) The immunogenetics of smallpox vaccination. J Infect Dis 196: 212-219. JID37808 [pii];10.1086/518794 [doi].